Funding for this research was provided by:
General Project of National Natural Science Foundation of China (81970180)
Key Science and Technology Support Project of Tianjin Science and Technology Bureau (20YFZCSY00800)
Received: 1 June 2022
Accepted: 28 June 2022
First Online: 7 July 2022
: This study was approved by the Ethics Committee of Tianjin First Central Hospital and was registered for clinical trials in the China Clinical Trial Registration Center (Trial registration: ChiCTR2000041054. Registered 17 December 2020, ExternalRef removed). All patients signed an informed consent form. The animal experiment protocol was approved by the Animal Care and Use Committee of Tianjin Medical University.
: All patients signed informed consent and also consented to the publication of these data.
: All authors declare that there are no conflicts of interest.